Evotec SE - American Depositary Shares (NQ:EVO)

2.140 -0.290 (-11.93%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 14, 2026 Add to My Watchlist

Price and Volume

Volume	270,919
Open	2.170
Bid (Size)	2.130 (4,200)
Ask (Size)	2.140 (4,100)
Prev. Close	2.430
Today's Range	2.095 - 2.195
52wk Range	2.308 - 4.415
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Evotec Q2 Earnings Call Highlights ↗

Today 9:03 EDT

Evotec (NASDAQ:EVO) reported preliminary unaudited results for the second quarter and first half of 2026 and lowered its full-year outlook, citing delayed strategic partnership revenue, slower...

Via MarketBeat

Evotec Appoints Rui Wang as Head of Global In Silico and AI

June 02, 2026

Via ACCESS Newswire

Performance

YTD	-32.7%	-32.7%
1 Month	-23.6%	-23.6%
3 Month	-23.0%	-23.0%
6 Month	-43.1%	-43.1%
1 Year	-48.1%	-48.1%

More News

Evotec SE Successfully Placed €116.1 Million Convertible Bonds

May 12, 2026

Via ACCESS Newswire

Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall

May 04, 2026

Via ACCESS Newswire

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Evotec Receives Grants to Advance Tuberculosis Treatment

April 30, 2026

Via ACCESS Newswire

Evotec Announces New Nomination to Board of Directors

April 29, 2026

Via ACCESS Newswire

Evotec SE to Announce First Quarter 2026 Results on May 6, 2026

April 29, 2026

Via ACCESS Newswire

Evotec Announces Chief Financial Officer Transition

April 24, 2026

Via ACCESS Newswire

Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer

April 15, 2026

Via ACCESS Newswire

Evotec (EVO) Q3 2025 Earnings Call Transcript ↗

April 08, 2026

Via The Motley Fool

Evotec Nominates Dieter Weinand as Supervisory Board Chairman

April 07, 2026

Via ACCESS Newswire

Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026

April 01, 2026

Via ACCESS Newswire

Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer

April 01, 2026

Via ACCESS Newswire

Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses

March 23, 2026

Via ACCESS Newswire

Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation

March 19, 2026

Via ACCESS Newswire

Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

January 08, 2026

Via ACCESS Newswire

Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations

January 02, 2026

Via ACCESS Newswire

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

December 08, 2025

Via ACCESS Newswire

Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome

December 04, 2025

Via ACCESS Newswire

Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

November 12, 2025

Via ACCESS Newswire

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

November 05, 2025

Via ACCESS Newswire

In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties

November 04, 2025

Via ACCESS Newswire

Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025

October 29, 2025

Via ACCESS Newswire

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

October 27, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Evotec SE - American Depositary Shares publicly traded?

Yes, Evotec SE - American Depositary Shares is publicly traded.

What exchange does Evotec SE - American Depositary Shares trade on?

Evotec SE - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Evotec SE - American Depositary Shares?

The ticker symbol for Evotec SE - American Depositary Shares is EVO on the Nasdaq Stock Market

What is the current price of Evotec SE - American Depositary Shares?

The current price of Evotec SE - American Depositary Shares is 2.140

When was Evotec SE - American Depositary Shares last traded?

The last trade of Evotec SE - American Depositary Shares was at 07/14/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.